CALZF
Price
$0.83
Change
-$0.02 (-2.35%)
Updated
Aug 4 closing price
Capitalization
534.04M
CBSC
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Aug 14 closing price
Capitalization
6.08M
Interact to see
Advertisement

CALZF vs CBSC

Header iconCALZF vs CBSC Comparison
Open Charts CALZF vs CBSCBanner chart's image
Polynovo
Price$0.83
Change-$0.02 (-2.35%)
Volume$20K
Capitalization534.04M
Cardiac Biotech Solutions
Price$0.04
Change-$0.00 (-0.00%)
Volume$240.53K
Capitalization6.08M
CALZF vs CBSC Comparison Chart in %
Loading...
CALZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CALZF vs. CBSC commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CALZF is a Hold and CBSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (CALZF: $0.83 vs. CBSC: $0.04)
Brand notoriety: CALZF and CBSC are both not notable
CALZF represents the Medical/Nursing Services, while CBSC is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CALZF: 338% vs. CBSC: 647%
Market capitalization -- CALZF: $534.04M vs. CBSC: $6.08M
CALZF [@Medical/Nursing Services] is valued at $534.04M. CBSC’s [@Pharmaceuticals: Other] market capitalization is $6.08M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.31B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CALZF’s FA Score shows that 0 FA rating(s) are green whileCBSC’s FA Score has 1 green FA rating(s).

  • CALZF’s FA Score: 0 green, 5 red.
  • CBSC’s FA Score: 1 green, 4 red.
According to our system of comparison, CBSC is a better buy in the long-term than CALZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CALZF’s TA Score shows that 5 TA indicator(s) are bullish while CBSC’s TA Score has 2 bullish TA indicator(s).

  • CALZF’s TA Score: 5 bullish, 4 bearish.
  • CBSC’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CALZF is a better buy in the short-term than CBSC.

Price Growth

CALZF (@Medical/Nursing Services) experienced а 0.00% price change this week, while CBSC (@Pharmaceuticals: Other) price change was -3.85% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +4.58%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

Industries' Descriptions

@Medical/Nursing Services (+1.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CALZF($534M) has a higher market cap than CBSC($6.08M). CALZF YTD gains are higher at: -19.837 vs. CBSC (-42.308). CALZF has higher annual earnings (EBITDA): 4.05M vs. CBSC (-1.41M). CALZF has more cash in the bank: 46M vs. CBSC (156K). CBSC has less debt than CALZF: CBSC (143K) vs CALZF (15.4M). CALZF has higher revenues than CBSC: CALZF (103M) vs CBSC (60.7K).
CALZFCBSCCALZF / CBSC
Capitalization534M6.08M8,780%
EBITDA4.05M-1.41M-287%
Gain YTD-19.837-42.30847%
P/E Ratio151.50N/A-
Revenue103M60.7K169,687%
Total Cash46M156K29,487%
Total Debt15.4M143K10,769%
FUNDAMENTALS RATINGS
CALZF vs CBSC: Fundamental Ratings
CALZF
CBSC
OUTLOOK RATING
1..100
3180
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
75100
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
28n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CALZF's Valuation (87) in the null industry is in the same range as CBSC (100). This means that CALZF’s stock grew similarly to CBSC’s over the last 12 months.

CALZF's Profit vs Risk Rating (100) in the null industry is in the same range as CBSC (100). This means that CALZF’s stock grew similarly to CBSC’s over the last 12 months.

CALZF's SMR Rating (75) in the null industry is in the same range as CBSC (100). This means that CALZF’s stock grew similarly to CBSC’s over the last 12 months.

CALZF's Price Growth Rating (64) in the null industry is in the same range as CBSC (64). This means that CALZF’s stock grew similarly to CBSC’s over the last 12 months.

CBSC's P/E Growth Rating (3) in the null industry is significantly better than the same rating for CALZF (100). This means that CBSC’s stock grew significantly faster than CALZF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CALZFCBSC
RSI
ODDS (%)
Bearish Trend 1 day ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
73%
Bullish Trend 24 days ago
69%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CALZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFMLX17.30N/A
N/A
Morgan Stanley Inst Next Gen Em Mkts L
BMSTX15.00N/A
N/A
MFS Blended Research Mid Cap Eq R3
PURYX59.06N/A
N/A
Putnam Research Y
ITCTX25.88N/A
N/A
VY® T. Rowe Price Capital Apprec S2
GICPX64.14N/A
N/A
Gabelli Global Growth AAA

CALZF and

Correlation & Price change

A.I.dvisor tells us that CALZF and SERA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CALZF and SERA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALZF
1D Price
Change %
CALZF100%
N/A
SERA - CALZF
25%
Poorly correlated
N/A
BBLG - CALZF
18%
Poorly correlated
-6.38%
CHEOF - CALZF
11%
Poorly correlated
N/A
CHEOY - CALZF
7%
Poorly correlated
+3.10%
CBSC - CALZF
6%
Poorly correlated
N/A
More

CBSC and

Correlation & Price change

A.I.dvisor tells us that CBSC and LNSR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBSC and LNSR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBSC
1D Price
Change %
CBSC100%
N/A
LNSR - CBSC
20%
Poorly correlated
+1.20%
CALZF - CBSC
6%
Poorly correlated
N/A
BBLG - CBSC
3%
Poorly correlated
-6.38%
BLOZF - CBSC
3%
Poorly correlated
+1.98%
CHEOF - CBSC
1%
Poorly correlated
N/A
More